Real-time enrollment status for this hepatocellular carcinoma clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 8:49 AM UTC
| NCT Number | NCT03897543 |
| Recruiting Status | Recruiting |
| Condition | Hepatocellular Carcinoma |
| Phase | Clinical Trial |
| Target Enrollment | 48 participants |
| Active Locations | 2 sites in the US |
| Sponsor | Abivax S.A. |
| Last Updated on CT.gov | March 26, 2021 (Mar 26, 2021) |
As of March 2, 2026: Clinical trial NCT03897543 is currently recruiting participants. This clinical trial study for hepatocellular carcinoma is actively seeking new participants at 2 locations across the United States. The study is sponsored by Abivax S.A.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT03897543 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 2 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT03897543 was last updated Mar 26, 2021 (March 26, 2021). HelloStudys verifies this status automatically.